Therapeutic gene delivery to the skin.
The skin represents a site for treatment of cutaneous and systemic disease and is the most accessible somatic tissue for therapeutic gene transfer in humans. Monogenic hereditary skin diseases, such as ichthyosis and epidermolysis bullosa subtypes, and disorders characterized by low levels of polypeptides in the systemic circulation, are current central foci of efforts in cutaneous-gene transfer. Additional efforts center on the treatment of wounds and malignancies. Recent developments in models of gene delivery to the skin underscore key challenges that must be met before successful treatment of human disease by cutaneous gene delivery can be achieved.
Khavari
P A
PA
Dermatology Service, V.A. Palo Alto Health Care System, CA 94304, USA. khavari@cmgm.stanford.edu
D000818:Animals; D004195:Disease Models, Animal; D018014:Gene Transfer Techniques; D006801:Humans; D012867:Skin / Q000378:metabolism*